Lenvatinib in the 1st line for uHCC treatment
Nevena Damnjanov, MD of Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses the use of lenvatinib in the first line setting for the treatment of hepatocellular carcinoma....
Author: obr
Added: 06/20/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | University of Pennsylvania